Caption: Scanning electron micrograph of the Ebola virus

Source: NIAID

A Promising Experimental Ebola Drug Goes Overlooked

Sarepta a biotech company in Cambridge, Mass., has a small supply of an Ebola drug that has shown promising results in lab trials. Yet the U.S. government seems to be ignoring the company

More on Technology

Recent

Read

Shared

Discussed

Last Updated: 01:42 pm Market Summary

S&P500 1897.11 10.35
DJIA 16356.68 -23.73
NASDAQ 4295.57 37.132
Stoxx 50 2927.3 -34.94
FTSE 100 6267.07 -43.22
DAX 8717.76 -132.51
Nikkei 15111.23 578.72
Topix 1224.34 47.12
Hang Seng 23070.26 47.05

Stock Quotes Market data is delayed at least 15 minutes

Company Lookup

Recently in Technology

SBUX:US 74.36 USD 0.81
AAPL:US 99.28 USD 1.61
AMZN:US 302.97 USD -0.67
GOOG:US 516.51 USD 5.34
SHLD:US 34.30 USD 5.89
Request Investor Kit

Sponsored Links

Buy a link now!